To ask the Secretary of State for International Development, whether her Department is providing support to organisations or projects researching a covid-19 vaccine.
29 April 2020
The UK is at the forefront of efforts to develop coronavirus vaccines. As agreed by the G20, we support a global approach to the rapid development and scaled up manufacture of vaccines with equitable access to all who need them, including in the poorest countries. We are working with international partners, industry and researchers to support an approach to accelerate research and development, scale up global manufacturing capacity and ensure funding to deliver this aim.
The UK is a strong supporter of the Coalition for Epidemic Preparedness Innovations (CEPI), which is supporting the development of vaccines that will be available throughout the world. We have pledged £250 million of UK aid to CEPI, the biggest donation of any country to date. CEPI is supporting the development of 10 COVID-19 vaccine candidates, such as the University of Oxford’s vaccine research.
UK aid has also supported Gavi, the Vaccine Alliance for 20 years. We are its biggest donor, helping to immunise over 760 million children and saving over 13 million lives worldwide. Gavi will play a key role in making a new COVID-19 vaccine available and affordable.
UK support, through CEPI, GAVI and others, will help facilitate the end-to-end development and distribution of a successful vaccine.